• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宫颈癌指南、预防与筛查策略:来自巴西和智利的经验

Cervical cancer guidelines, prevention and screening strategies: experiences from Brazil and Chile.

作者信息

Claro Itamar Bento, Lima Luciana Dias de, Almeida Patty Fidelis de

机构信息

Instituto Nacional de Câncer José Alencar Gomes da Silva. Rua Marquês de Pombal 125 7º andar, Centro. 20230-240 Rio de Janeiro RJ Brasil.

Departamento de Administração e Planejamento em Saúde, Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz. Rio de Janeiro RJ Brasil.

出版信息

Cien Saude Colet. 2021 Oct;26(10):4497-4509. doi: 10.1590/1413-812320212610.11352021. Epub 2021 May 27.

DOI:10.1590/1413-812320212610.11352021
PMID:34730638
Abstract

This article analyzes cervical cancer control policies and actions in Brazil and Chile, focusing on prevention and screening. We adopted a comparative approach to identify similarities and differences in guidelines and cervical cancer prevention and screening strategies between the two countries. We used the following data collection techniques: analysis of official documents and secondary data, consultations with experts, government officials and program coordinators, and literature review. The findings show that Chile has a well-structured program with centralized decision-making and a system that permits monitoring of actions. Brazil on the other hand faces ongoing issues with lack of coordination and shortcomings in the follow-up of women with abnormal test results. The following challenges to consolidating cervical cancer screening stand out in Brazil: lack of active tracking of the target population; absence of a test quality assurance system; and inadequate follow-up of women with abnormal test results. Both countries need to increase coverage and implement organized screening.

摘要

本文分析了巴西和智利的宫颈癌防控政策与行动,重点关注预防和筛查。我们采用比较方法来识别两国在指南以及宫颈癌预防和筛查策略方面的异同。我们使用了以下数据收集技术:分析官方文件和二手数据、咨询专家、政府官员和项目协调员以及文献综述。研究结果表明,智利有一个结构完善的项目,具备集中决策以及允许对行动进行监测的系统。另一方面,巴西面临着持续存在的协调问题以及对检测结果异常的女性后续跟进不足的问题。在巴西,巩固宫颈癌筛查面临以下突出挑战:缺乏对目标人群的积极追踪;缺乏检测质量保证体系;以及对检测结果异常的女性后续跟进不足。两国都需要提高覆盖率并实施有组织的筛查。

相似文献

1
Cervical cancer guidelines, prevention and screening strategies: experiences from Brazil and Chile.宫颈癌指南、预防与筛查策略:来自巴西和智利的经验
Cien Saude Colet. 2021 Oct;26(10):4497-4509. doi: 10.1590/1413-812320212610.11352021. Epub 2021 May 27.
2
[Early detection of cervical cancer in Chile: time for change].[智利宫颈癌的早期检测:变革之时]
Rev Med Chil. 2014 Aug;142(8):1047-55. doi: 10.4067/S0034-98872014000800012.
3
Development of mobile technologies for the prevention of cervical cancer in Santiago, Chile study protocol: a randomized controlled trial.智利圣地亚哥预防宫颈癌移动技术的开发研究方案:一项随机对照试验
BMC Cancer. 2017 Dec 13;17(1):847. doi: 10.1186/s12885-017-3870-8.
4
Selecting a mix of prevention strategies against cervical cancer for maximum efficiency with an optimization program.选择最佳组合的宫颈癌预防策略,通过优化程序实现最大效率。
Pharmacoeconomics. 2012 Apr;30(4):337-53. doi: 10.2165/11591560-000000000-00000.
5
Health workers' perspectives on barriers and facilitators to implementing a new national cervical cancer screening program in Ethiopia.卫生工作者对在埃塞俄比亚实施新的国家宫颈癌筛查计划的障碍和促进因素的看法。
BMC Womens Health. 2021 May 3;21(1):185. doi: 10.1186/s12905-021-01331-3.
6
[Human papillomavirus testing in cervical cancer screening at a public health service of Santiago, Chile].[智利圣地亚哥公共卫生服务机构宫颈癌筛查中的人乳头瘤病毒检测]
Rev Med Chil. 2015 Jan;143(1):56-62. doi: 10.4067/S0034-98872015000100007.
7
Effective cervical cytology screening programmes in middle-income countries: the Chilean experience.中等收入国家有效的宫颈细胞学筛查项目:智利的经验
Cancer Detect Prev. 2005;29(5):405-11. doi: 10.1016/j.cdp.2005.07.001. Epub 2005 Sep 26.
8
Health systems challenges in cervical cancer prevention program in Malawi.马拉维宫颈癌预防项目中的卫生系统挑战。
Glob Health Action. 2015 Jan 22;8:26282. doi: 10.3402/gha.v8.26282. eCollection 2015.
9
Population-based organized cervical cancer screening pilot program in France.法国基于人群的有组织宫颈癌筛查试点项目。
Eur J Cancer Prev. 2018 Sep;27(5):486-492. doi: 10.1097/CEJ.0000000000000365.
10
Barriers to cervical cancer screening in women attending the Family Medical Program in Niterói, Rio de Janeiro.在里约热内卢尼泰罗伊市参加家庭医疗项目的妇女中,宫颈癌筛查的障碍。
Arch Gynecol Obstet. 2013 Jan;287(1):53-8. doi: 10.1007/s00404-012-2511-3. Epub 2012 Aug 12.

引用本文的文献

1
Effects of screening coverage and screening quality assurance on cervical cancer mortality: Implication for integrated framework to monitor global implementation of cervical cancer screening programmes.筛查覆盖率和筛查质量保证对宫颈癌死亡率的影响:对监测全球宫颈癌筛查规划实施情况综合框架的启示。
J Glob Health. 2024 Oct 25;14:04189. doi: 10.7189/jogh.14.04189.
2
Impact of virtual education based on health belief model on cervical cancer screening behavior in middle-aged women: A quasi-experimental study.基于健康信念模型的虚拟教育对中年女性宫颈癌筛查行为的影响:一项准实验研究。
Cancer Rep (Hoboken). 2024 Apr;7(4):e2058. doi: 10.1002/cnr2.2058.
3
Screening and hospitalization of breast and cervical cancer in Brazil from 2010 to 2022: A time-series study.
2010 年至 2022 年巴西乳腺癌和宫颈癌的筛查和住院治疗:时间序列研究。
PLoS One. 2023 Oct 26;18(10):e0278011. doi: 10.1371/journal.pone.0278011. eCollection 2023.
4
Papanicolaou test in Brazil: analysis of the National Health Survey of 2013 and 2019.巴西巴氏涂片检查:2013 年和 2019 年国家健康调查分析。
Rev Saude Publica. 2023 Oct 20;57:55. doi: 10.11606/s1518-8787.2023057004798. eCollection 2023.
5
Recent changes in trends of mortality from cervical cancer in Southeastern Brazil.巴西东南部宫颈癌死亡率趋势的近期变化。
Rev Saude Publica. 2023 Apr 17;57:25. doi: 10.11606/s1518-8787.2023057004709. eCollection 2023.
6
Evaluation of histopathological examinations of the cervix diagnosed as "other neoplasms" on the Cancer Information System, Brazil, 2013-2020: a descriptive study.巴西 2013-2020 年癌症信息系统中诊断为“其他肿瘤”的宫颈组织病理学检查评估:一项描述性研究。
Epidemiol Serv Saude. 2022 Dec 2;31(3):e2022466. doi: 10.1590/S2237-96222022000300012. eCollection 2022.